Winslow Capital Management LLC Raises Position in Axon Enterprise, Inc $AXON

Winslow Capital Management LLC increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 43.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 375,580 shares of the biotechnology company’s stock after buying an additional 113,326 shares during the quarter. Winslow Capital Management LLC’s holdings in Axon Enterprise were worth $310,958,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Natixis purchased a new stake in shares of Axon Enterprise during the second quarter worth about $7,944,000. California Public Employees Retirement System grew its position in Axon Enterprise by 9.9% during the 2nd quarter. California Public Employees Retirement System now owns 122,689 shares of the biotechnology company’s stock worth $101,579,000 after purchasing an additional 11,086 shares during the last quarter. Cerity Partners LLC increased its stake in Axon Enterprise by 44.8% during the 2nd quarter. Cerity Partners LLC now owns 5,983 shares of the biotechnology company’s stock valued at $4,954,000 after purchasing an additional 1,851 shares in the last quarter. Federated Hermes Inc. increased its stake in Axon Enterprise by 3.1% during the 2nd quarter. Federated Hermes Inc. now owns 333,364 shares of the biotechnology company’s stock valued at $276,005,000 after purchasing an additional 10,157 shares in the last quarter. Finally, Quantum Portfolio Management LLC purchased a new position in shares of Axon Enterprise in the second quarter worth $493,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on AXON shares. Wall Street Zen lowered shares of Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Royal Bank Of Canada began coverage on Axon Enterprise in a research note on Monday, November 17th. They set an “outperform” rating and a $860.00 price target on the stock. Piper Sandler cut their price objective on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. JMP Securities reaffirmed a “market outperform” rating and set a $825.00 target price on shares of Axon Enterprise in a report on Monday, September 29th. Finally, Cowen reiterated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $815.00.

Axon Enterprise Stock Up 0.1%

Axon Enterprise stock opened at $550.95 on Monday. The business’s 50-day moving average price is $639.29 and its 200 day moving average price is $720.03. The company has a quick ratio of 2.89, a current ratio of 3.12 and a debt-to-equity ratio of 0.57. The firm has a market cap of $43.48 billion, a price-to-earnings ratio of 174.35, a price-to-earnings-growth ratio of 126.54 and a beta of 1.40. Axon Enterprise, Inc has a 52 week low of $469.24 and a 52 week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The firm had revenue of $710.64 million for the quarter, compared to analyst estimates of $704.83 million. During the same period in the previous year, the business earned $1.45 EPS. Axon Enterprise’s revenue for the quarter was up 30.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction dated Friday, November 7th. The shares were sold at an average price of $591.04, for a total value of $5,910,400.00. Following the completion of the transaction, the chief executive officer owned 3,023,982 shares in the company, valued at approximately $1,787,294,321.28. This represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer owned 93,592 shares in the company, valued at $66,813,456.96. This represents a 5.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,459 shares of company stock valued at $21,049,577 in the last ninety days. Company insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.